Merck & Company Inc

MRKHealthcare

Sentinellis Health Score

8.4/10

Financially healthy

Market Cap

$282.2B

Revenue

$64.9B

P/E Ratio

32.2x

AI Summary

Merck develops and sells prescription medicines for cancer, vaccines for diseases like HPV and rotavirus, and treatments for diabetes, HIV, and infectious diseases under brands like Keytruda, Gardasil, Januvia, and Bridion [Company Overview]. The company also operates a substantial animal health business selling livestock vaccines, companion animal treatments like Bravecto flea medication, and livestock intelligence solutions through its Allflex brand [Company Overview]. Merck partners with other pharma companies including Daiichi Sankyo, AstraZeneca, and Moderna to co-develop experimental treatments across multiple disease areas [Company Overview].

Merck is a major pharmaceutical company that develops and sells prescription drugs, vaccines, and animal health products worldwide [Yahoo Finance]. Its blockbuster cancer drug Keytruda is a cornerstone revenue driver, and the company recently announced breakthrough Phase 3 trial results for a new cancer treatment targeting endometrial cancer [Yahoo Finance]. With a market cap of $282.2 billion and strong margins, Merck operates as one of the largest drugmakers globally, though it faces typical pharmaceutical risks including patent cliffs and regulatory hurdles [Yahoo Finance].

Merck demonstrates strong profitability and a solid balance sheet with high margins and manageable debt levels [Yahoo Finance].

Confidence8/10